Bullous Keratopathy Clinical Trial
Official title:
Study of the Effects of Riboflavin/ Ultraviolet-A Corneal Cross-linking
Recently, riboflavin (0.1%) and ultraviolet-A (UVA) collagen cross-linking (C3R) has shown potential to improve the signs and symptoms of bullous keratopathy .The objective of this study is to demonstrate the effects of C3R to treat bullous keratopathy.
n/a
Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03248037 -
Trial of Netarsudil for Prevention of Corticosteroid-induced Intraocular Pressure Elevation
|
Phase 3 | |
Enrolling by invitation |
NCT05956535 -
Air Optix® Night and Day® Aqua Therapeutic Wear
|
||
Recruiting |
NCT02020044 -
Outcome After Descemet Membrane Endothelial Keratoplasty (DMEK) and Ultra-thin Descemet Stripping Automated Endothelial Keratoplasty (DSAEK)
|
N/A | |
Recruiting |
NCT03407755 -
Air Versus SF6 for Descemet's Membrane Endothelial Keratoplasty (DMEK)
|
N/A | |
Completed |
NCT01448213 -
Comparison of Two Steroid Regimens to Prevent Transplant Rejection After Corneal Transplant (DMEK)
|
Phase 2 | |
Completed |
NCT03450954 -
Long Term Results of Amniotic Membrane Transplant in Bullous Keratopathy Patients
|
N/A | |
Completed |
NCT01926535 -
Amniotic Membrane Graft In Syntomathic Bullous Keratopathy
|
Phase 2 | |
Completed |
NCT03763721 -
The ADVISE Study: Advanced Visualization In Corneal Surgery Evaluation
|
N/A | |
Completed |
NCT05891106 -
AONDA Therapeutic Indication Study I
|
||
Active, not recruiting |
NCT04894110 -
Study of Safety and Tolerability of EO2002 in the Treatment of Corneal Edema
|
Phase 1 | |
Completed |
NCT00659308 -
Amniotic Membrane and Anterior Stromal Puncture to the Treatment of Symptomatic Bullous Keratopathy
|
N/A | |
Completed |
NCT01122043 -
The SNEC DSAEK EndoGlide Clinical Trial
|
N/A | |
Completed |
NCT00800111 -
Study of Endothelial Keratoplasty Outcomes
|
N/A | |
Recruiting |
NCT05636579 -
Study to Assess Safety and Tolerability of Multiple Doses of EO2002
|
Phase 1 | |
Recruiting |
NCT04319848 -
Safety and Efficacy of Tissue Engineered Endothelial Keratoplasty
|
Phase 1 | |
Recruiting |
NCT05436665 -
The Belgian Endothelial Surgical Transplant of the Cornea
|
N/A | |
Not yet recruiting |
NCT02736877 -
Corneal Transplantation Guided by OCT RESCAN
|
N/A |